Filip Petronijevic

Filip Petronijevic is a Principal Scientist at Bolt Biotherapeutics, Inc., with a focus on advancing synthetic routes to new antibiotics through organometallic chemistry. Prior experience includes a Senior Scientist role at Genentech, where Filip concentrated on antibiotic discovery, and as a Scientist at Princeton University, contributing to innovative photoredox catalysis research. Filip's doctoral studies at the University of Pittsburgh under Professor Peter Wipf led to the development of new methodologies for indole construction and the total synthesis of cycloclavine. Early research experience includes positions at The Ohio State University and the University of Illinois at Urbana-Champaign, focusing on diazomethane addition and peptide synthesis methodologies, respectively. Filip holds a Ph.D. in Organic Chemistry from the University of Pittsburgh and a B.Sc. in Chemistry/Organic Chemistry from the University of Belgrade.